Mariner’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Mariner’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-117,721	Closed	-$1.45M	–	3627
2024 Q4	$1.45M	Buy	117,721 +30,776	+35%	+$353K	﹤0.01%	1396
2024 Q3	$989K	Hold	86,945	–	–	﹤0.01%	1610
2024 Q2	$621K	Hold	86,945	–	–	﹤0.01%	1889
2024 Q1	$583K	Buy	86,945 +44,445	+105%	+$306K	﹤0.01%	1912
2023 Q4	$276K	Hold	42,500	–	–	﹤0.01%	2424
2023 Q3	$401K	Buy	42,500 +20,000	+89%	+$241K	﹤0.01%	1921
2023 Q2	$314K	Hold	22,500	–	–	﹤0.01%	2083
2023 Q1	$422K	Hold	22,500	–	–	﹤0.01%	1792
2022 Q4	$310K	Buy	+22,500	New	+$345K	﹤0.01%	2007

Other funds holding CDMO

TCWM

Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mariner's CDMO Position: Q1 2025 in Review

Mariner sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 117,721 shares — an estimated $1.45M sold.

Mariner first reported a position in CDMO in Q4 2022 and held it in 9 quarters. The position peaked at $1.45M in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

Mariner reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Mariner sold 117,721 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.45M.
Mariner first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2022 and held it in 9 quarters.
Mariner's Avid Bioservices, Inc. Common Stock position peaked at $1.45M in Q4 2024.
2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Mariner's 13F filing for Q1 2025, filed 15 May 2025.